Healthtech & Wellness VC Funds

Abenteuer Ventures is a Menlo Park-based venture firm that focuses on angel investments in emerging technologies across sectors like tech, bio-science, and space exploration. The firm actively invests in early-stage startups, emphasizing innovative solutions that have the potential to make a significant impact on industries and society. Abenteuer Ventures collaborates with various syndicates, including notable names like Flight VC and Hack VC, giving it access to a wide range of deals. Their portfolio includes companies across a diverse array of industries, such as Akash Systems, which pioneers satellite communications technology, DroneSeed, offering drone-based reforestation solutions, and BillionToOne, which develops genetic testing technologies. Abenteuer Ventures typically invests in companies that align with its mission to leverage technology for transformative change, supporting everything from smart robotics to advanced medical devices. The firm’s approach centers on helping startups navigate early challenges while providing access to a network of strategic partners and investors. Their investments usually focus on seed-stage rounds, and they continue to support portfolio companies through follow-on funding and expert guidance.

Abies Ventures is a Tokyo-based venture capital firm that specializes in deep tech investments, aiming to tackle global issues like environmental degradation and food shortages through science and advanced technologies. Established in 2017, the firm focuses on early-stage companies with innovative solutions in areas such as AI, robotics, quantum computing, and biotech. Their portfolio includes cutting-edge startups like Synspective, Telexistence, and Mighty Buildings, reflecting their commitment to building sustainable, tech-driven solutions. Abies Ventures leverages its strong global network, partnering with large corporations, research institutes, and government agencies to help startups scale internationally. The fund is led by experienced venture founders like Fuyuki Yamaguchi and Sota Nagano, who bring extensive expertise in venture investment and scaling companies across Japan and the U.S. Their investment strategy centers on fostering deep tech companies with high impact potential, particularly in areas where finance, technology, and market dynamics may not always align. Abies Ventures helps bridge these gaps by providing strategic advice and connecting startups with key players to enhance their growth trajectory​.

Abingworth, founded in 1973, is a transatlantic life sciences investment firm with a robust portfolio and a strategic focus on turning innovative science into transformative medical treatments. With offices in London, Boston, and San Francisco, Abingworth has invested in over 179 companies, resulting in 73 IPOs and 46 M&As. The firm operates across three main investment stages: seed and early-stage, development stage, and clinical co-development, and typically invests between $500,000 to $2 million in initial rounds, supporting portfolio companies through subsequent funding stages. Notable investments include Adaptate Biotherapeutics, Jasper, and Tizona Therapeutics. Abingworth's team, led by Managing Partners Tim Haines and Kurt von Emster, brings decades of experience in life sciences and venture capital. The firm is deeply embedded in key biotech hubs, facilitating productive interactions with entrepreneurs and access to top-tier scientific talent. The firm emphasizes long-term partnerships, providing not just capital but also strategic guidance in areas such as clinical development, regulatory approval, and commercialization. Abingworth's recent integration with Carlyle Group underscores its commitment to expanding its impact in the global healthcare investment ecosystem. Startups seeking investment from Abingworth should have groundbreaking science with the potential to materially improve patient outcomes. The firm values deep industry expertise, strong leadership, and a clear path to transformative impact.

Able Partners, founded in 2016 and based in New York City, is a venture capital firm that focuses on investing in early-stage companies aiming to improve daily lives through health and wellness. The firm is known for its support of passionate entrepreneurs and inspiring brands across various industries including consumer products, health tech, and wellness. Their diverse portfolio includes investments in companies such as Clare, a direct-to-consumer paint company; Alto Neuroscience, a company focused on precision psychiatry; Little Otter, a mental health service for children and families; and Kindred, a network for professional caregivers. Other notable investments are Beam Impact, Vivvi, and Capable Health. Able Partners has made over 60 investments and has achieved multiple successful exits. Key exits include Alto Neuroscience, Stretch*d, and Capable Health, showcasing their ability to support companies from early stages to successful outcomes. The firm is led by co-founders Lisa Blau and Amanda Eilian, who bring extensive experience in consumer-focused investments and entrepreneurship. Their investment strategy emphasizes not only providing capital but also leveraging their extensive networks and expertise to help portfolio companies achieve their full potential.

Abstract Ventures is a San Francisco-based VC firm founded in 2016, focusing on early-stage investments across biotech, consumer products, crypto, and enterprise frontier tech. The firm has gained a reputation for backing innovative and high-potential startups, with a portfolio that includes successes like Rippling and Material, the latter achieving unicorn status in 2022. Abstract Ventures primarily targets investments within the U.S., engaging in Seed and Series A rounds with typical check sizes ranging from $5 to $15 million. Their strategy blends flexibility with strategic partnerships, often co-investing with other VCs and leading rounds when they see transformative potential. Abstract is known for being founder-friendly, offering not just capital but also access to a wide network of industry experts, experienced entrepreneurs, and investors who can provide significant strategic value. In 2024, Abstract maintained a proactive stance, completing 16 new investments in companies such as Unify and Thirddimension.ai. The firm’s small yet powerful team is spearheaded by founder and General Partner Ramtin Naimi, who, along with four other partners, leverages years of investment experience and market insight from their base in San Francisco. Abstract Ventures advises founders to approach with a robust market strategy, proven product traction, and genuine storytelling. Rather than solely evaluating polished decks, the firm seeks authenticity and conviction in a startup’s vision. They primarily source deals through referrals and their network, emphasizing relationships and strategic alignment. With this approach, Abstract has carved out a distinctive presence in the early-stage VC landscape, empowering founders from idea to growth phase.

AC Ventures (ACV) is a prominent venture capital firm focused on early-stage technology investments in Indonesia and Southeast Asia. Since its formation in 2019, the firm has built a robust portfolio of over 120 startups, including notable names like Xendit, Carsome, and Ula. ACV's industry focus spans fintech, logistics, e-commerce, and consumer technology, with an emerging interest in climate tech. Geographically, ACV targets Indonesia and the broader Southeast Asian market. The firm’s investment strategy is early-stage centric, often being the first institutional investor in startups. They typically invest $2 million per company, reserving a significant portion for follow-on investments. ACV’s approach is deeply thematic and research-driven, focusing on scalable business models and market comparability to make quick, informed decisions. ACV’s team is led by experienced investors, including co-founders Michael Soerijadji and Adrian Li, and managing partner Helen Wong. The team is based primarily in Indonesia but also has offices in Singapore and Malaysia. Their leadership is known for its diversity, with 50% of senior roles filled by women. The fund is known for its hands-on value creation, providing startups with extensive support in business development, strategic partnerships, talent acquisition, and compliance. ACV’s recent Fund V, targeting $250 million, underscores its commitment to driving economic and societal impact through technology investments in the region​.

Acadian Ventures is an early-stage VC firm that focuses on the future of work, helping to build technologies that make work better, more equitable, and productive. Founded in 2019 by Jason Corsello, Acadian Ventures targets pre-seed, seed, and early Series A companies globally, with an emphasis on work tech, particularly in areas like intelligent work applications, work infrastructure, and new regulatory and compliance solutions. The firm typically invests between $500K to $1M, often co-investing alongside other VCs, and prefers to "fast follow" rather than lead rounds. Their hands-on approach and deep industry expertise have garnered them a high reputation among founders, with portfolio companies such as TechWolf and Compa praising their value as advisors. Anchored by notable LPs like ServiceNow Ventures, Acadian recently closed its second fund, a $30M commitment, nearly tripling their assets under management. They pride themselves on being highly engaged investors, often joining company boards as observers to support founders​.

Accel is a renowned venture capital firm known for its strategic investments across various stages and sectors. Founded in 1983, Accel has played a pivotal role in the success of numerous high-profile companies. Some of its most notable investments include Facebook, Dropbox, Spotify, and Slack, showcasing its strength in identifying and backing transformative technology companies early on. The firm's investment strategy focuses on seed and Series A funding, ensuring deep engagement with startups from their inception. Accel emphasizes a collaborative approach, providing not just capital but also mentorship and strategic support to help entrepreneurs build market-defining businesses. This hands-on involvement has led Accel to lead investments in over 70% of its portfolio companies​. Accel operates globally, with key offices in Silicon Valley, London, and Bangalore, enabling it to tap into entrepreneurial talent worldwide. The firm has recently closed on several funds totaling $3.05 billion, aimed at supporting early-stage startups and growth rounds for more mature companies​​. In 2023, Accel made significant investments in companies like Blackpoint Cyber, Headway, and Cyera, reflecting its commitment to diverse sectors such as cybersecurity, mental health, and data protection​​. This broad sector focus, combined with a global investment perspective, positions Accel as a key player in the venture capital landscape, continuously driving innovation and supporting exceptional entrepreneurs around the world.

Accelerace is one of the most prominent pre-seed investors and startup accelerators in the Nordics, headquartered in Copenhagen. Founded in 2008, it has supported over 700 startups, including high-profile companies like Trustpilot, Templafy, and Coinify. Accelerace focuses on providing early-stage startups with capital and mentorship, investing up to 1 million DKK through standardized convertible loans. Their investment strategy targets industries such as fintech, healthtech, climatetech, SaaS, and e-commerce, helping startups build scalable solutions across these sectors. The firm’s accelerator program is a comprehensive seven-week initiative designed to prepare startups for fundraising, offering support with pitching, business development, and investor connections. Startups that graduate from the program gain access to the Accelerace Allstars community, a lifelong network of successful founders and industry experts who provide ongoing mentorship and strategic advice. Notable alumni include Donkey Republic and Actimo, which both achieved successful exits. With over 600 investments and a solid presence in Denmark, the Baltics, and other European regions, Accelerace continues to play a pivotal role in shaping the future of innovation in Europe.

Accelerate Blue Fund is a venture fund exclusively supporting startups spun out from the University of Michigan. With a focus on early-stage investments, the fund helps bridge the gap between initial seed funding and larger VC rounds for companies commercializing U-M intellectual property. Their portfolio spans innovative sectors like AI (MemryX), 3D printing (Ulendo), and healthtech (Auricle), positioning them at the forefront of tech and life sciences. Based in Ann Arbor, the fund provides hands-on mentorship, intellectual property support, and business guidance. Startups looking to engage should demonstrate strong market validation and customer insights.

Accelerated Ventures, based in San Mateo, California, is a venture capital firm focused on early-stage investments in tech and life sciences. The firm has built a diverse portfolio that includes notable companies such as Telesentry, Amnesty, and Diag-X. Their investment strategy emphasizes sectors like HealthTech and retail, aiming to support innovative startups in these industries. With a portfolio count of six companies, Accelerated Ventures provides funding and strategic guidance to help these startups scale and succeed. Key investments like Telesentry and Diag-X highlight their commitment to fostering growth in tech and healthcare. The firm is led by experienced professionals who bring a wealth of knowledge and expertise to their investment approach, ensuring that each portfolio company receives the support needed to thrive in competitive markets.

Access Bridge Ventures (ABV) is an early-stage venture capital fund with a focus on the Middle East, North Africa, and Pakistan (MENAP). With a fund size of $35 million, ABV looks to back startups in sectors like HealthTech, FinTech, SaaS, e-commerce, and marketplaces. Notable investments include Jawaker, Mumzworld, and Vezeeta. ABV often leads funding rounds and provides ongoing strategic support through its deep regional networks and operational expertise. The fund prioritizes capital-efficient, scalable ventures with strong market traction and innovative teams. While primarily investing in the MENAP region, they will occasionally consider startups from outside this geography if aligned with their sector interests. ABV aims for long-term growth and clear exit paths, and prefers startups with a distinct competitive advantage. Led by Issa Aghabi, a veteran in MENA venture capital, the ABV team includes experts like Imad Ghandour and Magellan Makhlouf, bringing extensive investment and operational experience. The team operates mainly out of Saudi Arabia and the UAE, actively sourcing deals and supporting their portfolio with hands-on engagement. Startups are encouraged to approach with a clear pitch that aligns with their strategic interests.

Access Venture Partners (AVP), based in Westminster, Colorado, has been a key player in the venture capital landscape since 1999. AVP focuses on early-stage investments, primarily in seed and Series A rounds, with particular interest in sectors such as cybersecurity, enterprise SaaS, and managed marketplaces. They look for startups with scalable business models and a clear path to significant market opportunities, often investing between $250k and $500k initially and maintaining reserves for follow-on support. The firm's portfolio boasts successful startups like Red Canary, LogRhythm, and Bonusly, reflecting their commitment to innovative technology companies in the Mountain West region and beyond. AVP values a hands-on approach, offering not just capital but also extensive operational support, leveraging over 100 combined years of expertise among its team members. Co-founded by Frank Mendicino III, who has a strong background in product development and sales, AVP's team includes Brian Wallace, an expert in venture capital finance and legal matters, and Eric Shu and Alex Houghtalin, who bring diverse experiences in strategy and entrepreneurship. Access Venture Partners prides itself on its founder-first philosophy, actively supporting the entrepreneurial community through mentorship, network introductions, and strategic guidance. This approach has enabled them to foster robust relationships with founders and help them navigate the critical early stages of growth

Accion Venture Lab is an early-stage venture fund focused on empowering inclusive fintech startups that serve underserved and low-income populations globally. Established as part of Accion, a nonprofit dedicated to financial inclusion, Venture Lab provides seed-first capital paired with extensive strategic and operational support to help startups scale and overcome early challenges. Their diverse portfolio features innovative companies like Apollo Agriculture, which offers tech-driven financing to smallholder farmers in Kenya and Zambia, and Bababos, an Indonesian platform that supports small-scale manufacturers with raw materials and financing solutions. With a geographic reach that spans Latin America, the Caribbean, sub-Saharan Africa, the Middle East, North Africa, Southeast Asia, and even parts of the U.S., Accion Venture Lab's commitment is global. The fund targets industries such as digital lending, insurtech, personal financial management, and MSME-focused solutions, identifying startups with a mission to address systemic barriers to financial access. Their strategy is unique in that they prefer being the first institutional investor, ensuring startups receive not just capital but high-touch mentorship and strategic guidance. In 2019, Accion Venture Lab boosted its support efforts by launching a $23 million fund aimed at deepening their investment into inclusive fintech. Their approach prioritizes not only financial backing but also leveraging their deep-rooted expertise in financial inclusion to provide hands-on operational assistance. The team is led by seasoned Managing Partners Amee Parbhoo and Rahil Rangwala, who bring years of experience in fintech, impact investing, and scaling social enterprises. Founders looking for support from Venture Lab should demonstrate impactful, scalable solutions with clear pathways to financial inclusion.

Accomplice Ventures, founded in 2015 and based in Boston, Massachusetts, is a prominent seed-led venture capital firm. The firm specializes in technology startups across various sectors including cybersecurity, eSports, data analytics, SMB software, emerging hardware platforms, and marketplaces. Notable investments by Accomplice include leading tech companies such as DraftKings, AngelList, Carbon Black, CoinList, Currencycloud, and FreshBooks. Their portfolio also features innovative firms like Hopper, Patreon, PillPack, SecurityScorecard, Veracode, and WHOOP. Accomplice has a significant track record of successful exits, with companies like Datadog, Snap, and DraftKings achieving substantial market presence and growth. Accomplice operates with a unique federated VC model, supporting initiatives such as the operator-angel movement through Spearhead and the blockchain sector via Accomplice Blockchain. They are also anchor LPs in numerous solo GP funds, reflecting their commitment to a diverse and dynamic investment strategy. The firm was initially part of Atlas Venture before the tech and life sciences groups split, with Accomplice focusing solely on tech investments. They have raised multiple funds, including $405 million for their final fund as of 2022, ensuring a robust financial backing for their portfolio companies. Accomplice's investment philosophy is centered on being high conviction, concentrated, and patient investors, dedicated to helping founders build successful, market-leading companies​.

Ace Management Partners is a technology-driven investment firm specializing in high-potential pre-IPO companies across industries like AI, FinTech, and other disruptive technologies. Their thematic funds reflect a commitment to identifying transformative opportunities globally, with a focus on markets showing rapid innovation and growth. They prioritize transparency by integrating advanced technology and real-time data to provide investors with unparalleled insights and clarity in decision-making. Their strategy is bolstered by partnerships with market leaders who collectively have experience exceeding $30 billion in private company transactions. While their specific average check size isn’t publicly disclosed, they emphasize operational excellence, suggesting a proactive, well-calibrated investment approach. The team comprises experts passionate about innovation and fostering strategic partnerships, combining decades of private equity and venture capital expertise. With a strong base in New York, they leverage global market insights and local expertise to deliver exceptional results in the evolving pre-IPO landscape.

ACME Capital is a prominent venture capital firm based in San Francisco, specializing in early-stage investments in disruptive technologies and innovative business models. Founded in 2013 by Hany Nada, Shervin Pishevar, and Scott Stanford, the firm focuses on sectors such as healthcare, financial services, and space exploration. Their notable investments include high-profile companies like Uber, Slack, and DraftKings, demonstrating a knack for identifying and nurturing industry leaders. ACME Capital's investment strategy is centered on supporting visionary founders who are tackling large-scale challenges with groundbreaking solutions. They emphasize platform shifts and technology breakthroughs that promise significant societal benefits. The firm typically leads funding rounds and provides not just capital, but also strategic guidance and operational support to help startups scale effectively. Geographically, ACME Capital has a strong focus on the United States, but their portfolio also includes companies with a global reach. Their commitment to diversity and inclusion is reflected in their investment choices, with a significant portion of their portfolio companies led by underrepresented founders. The team at ACME Capital includes experienced partners like Brian Yee and Alexander Fayette, who bring a wealth of expertise and a hands-on approach to their investment process. Entrepreneurs looking to engage with ACME Capital are encouraged to present bold, transformative ideas that have the potential to disrupt massive markets and drive significant impact.

ACME Capital, founded in 2018 and headquartered in San Francisco, is an early-stage venture capital firm specializing in transformative technologies and business model innovations. They invest in deep tech, hardware, disruptive consumer products, enterprise solutions, fintech, health, and web3 sectors. Notable portfolio companies include IonQ, Braintrust, Cue Health, Astra, Uhnder, and Forte, which exemplify ACME’s commitment to pioneering advancements and societal benefits. ACME's strategy emphasizes partnering with founders from ideation through to IPO, offering not just capital but also strategic support and valuable industry connections. They favor investments in companies demonstrating significant market traction and a clear path to scalability. Their recent Fund IV and adjacent Opportunity Fund raised over $300 million, underscoring their robust position in the venture capital landscape. ACME is also dedicated to diversity and inclusion, with a substantial portion of their investments and team members representing historically underrepresented groups. Key team members include Co-founders Hany Nada and Scott Stanford, who bring extensive experience in venture capital and entrepreneurship, enhancing ACME’s ability to guide startups toward successful exits.

Acorn Pacific Ventures, founded in 2015, is a venture capital firm based in San Mateo, California. The firm focuses on early and growth-stage technology companies, with a particular emphasis on cross-border investments between the U.S. and Asia. Their portfolio spans industries like e-commerce, AI, fintech, and healthcare, including notable investments in Reap, a Hong Kong-based fintech company, and PopChill, an e-commerce fashion platform. Acorn Pacific is known for its strategic expertise in cross-border expansion, helping startups navigate both Silicon Valley and Asia-Pacific markets. The firm targets companies that leverage proprietary technology and tackle complex challenges in Industry 4.0 and global supply chain transformation. Their typical investment range varies, but they are active in funding rounds from seed to Series B. Led by Chih-Kai Cheng and a team of experienced partners, Acorn Pacific provides not only capital but also operational support to help companies scale. Their portfolio includes ventures like Nuohui Health, Avatar Medical, and Proglix, demonstrating their strong presence across various tech-driven sectors​.

Acre Venture Partners, founded in 2016 and based in Santa Monica, California, is a venture capital firm focusing on innovations in food and agriculture. Acre's diverse portfolio includes notable investments in companies like Meati Foods, which specializes in clean, fungi-based protein meats and raised $50M in a Series B round co-led by Acre. Mori is another significant investment, providing silk-based coatings for food protection to reduce waste and extend shelf life. Inari, a unicorn company developing advanced seed breeding technology, is valued at $1.5B. Spoiler Alert is a B2B marketplace helping food businesses manage surplus food, thus reducing waste. Agrofy is an online platform for farm equipment and infrastructure products. Acre's investment strategy emphasizes sustainability and technological innovation in agrifood technology. Recently, Acre closed its third fund at $140 million, targeting advancements in agricultural robotics, AI, and machine learning. This includes investments in companies like Bonsai Robotics and Farm-ng, focusing on automation in agriculture. Leveraging extensive experience and strategic partnerships, including advisory roles from industry experts like Lynda Deakin from IDEO and Chef David Chang, Acre drives growth and innovation within its portfolio companies. The firm supports startups from pre-seed to Series B stages, ensuring they have the necessary resources and strategic guidance to succeed in the evolving agrifood tech sector.

Acrew Capital is a venture capital firm founded in 2019 and headquartered in Palo Alto, California. The firm focuses on investing in companies across various stages, from early to growth stages, emphasizing diversity and transformative technology. Acrew Capital operates two primary funds: the Long Term View (LTV) fund, which targets early-stage investments, and the Diversify Capital Fund (DCF), which focuses on growth-stage companies. The LTV fund invests in early-stage companies, typically in the Seed to Series A stages, with check sizes ranging from $1 to $15 million. The DCF fund is designed for growth-stage investments, offering $10 to $20 million per investment. Acrew Capital's investment strategy prioritizes deep domain expertise, diverse perspectives, and long-term commitments to their portfolio companies. The firm's core thesis areas include financial services, cybersecurity, data, augmented reality, virtual reality, web 3.0, and cryptocurrency sectors. Acrew Capital's notable investments include companies like Eden Health, BlockFi, and CipherTrace. They have successfully exited several investments through mergers and acquisitions, demonstrating a strong track record in identifying and nurturing high-potential startups​. The leadership team at Acrew Capital is composed of experienced professionals like Lauren Kolodny, Mark Kraynak, and Asad Khaliq, who bring extensive experience in venture capital and entrepreneurship. The firm's commitment to diversity is reflected in its team composition and investment approach, with a significant portion of its leadership being women or people of color​.

Act One Ventures, established in 2016 and based in Los Angeles, California, focuses on investing in early-stage companies, particularly in pre-seed and seed rounds. The firm primarily invests in sectors like e-commerce infrastructure, vertical SaaS, and fintech. Act One Ventures is known for its commitment to diversity, with over 70% of its portfolio companies led by women founders and those from underrepresented backgrounds. Notable investments by Act One Ventures include Cartwheel, a logistics and delivery software company; Dragonboat, a product portfolio management platform; Clovers, a human resources technology firm using conversational intelligence to enhance hiring practices; and Time Study, an AI-driven productivity tool for healthcare and enterprise applications. Act One Ventures takes a hands-on approach, working closely with founders to provide strategic guidance and support, helping startups navigate the challenges of early-stage growth. The firm's typical investment ranges from $500K to $3 million, reflecting its focus on providing substantial early support to its portfolio companies.

ACT Venture Capital, based in Dublin, Ireland, is an early-stage venture capital firm founded in 1994. The firm focuses on investing in high-potential technology companies across sectors such as AI, machine learning, enterprise software, deep tech, healthcare, and energy & climate. ACT has completed over 70 investments and manages around €627 million across multiple funds. Notable companies in ACT Venture Capital's portfolio include Cubic Telecom, a global connectivity management company; Ekco, a leading provider of cloud services; and Deciphex, which develops software solutions for digital pathology. The firm also backs companies like Gridbeyond, which focuses on intelligent energy management systems, and Provizio, an automotive safety technology company. ACT Venture Capital recently launched its sixth fund, ACT VI, with an initial close of €140 million, aiming to invest in 35 companies across its targeted sectors. This fund supports startups from seed to expansion stages, with the capacity to invest up to €10 million per company. The firm has a strong track record of successful exits, including the acquisition of SilverCloud Health by Amwell, Decawave by Qorvo, and Corvil by Pico. The leadership team at ACT includes John Flynn, Debbie Rennick, and John O’Sullivan, who bring extensive experience and expertise to the firm, supporting their portfolio companies through strategic guidance and robust networks.

ACT Venture Partners is an Amsterdam-based venture capital firm focusing on early-stage investments in deep-tech and enabling technologies across Europe, with additional strong ties to the Turkish market. They target sectors such as AI, IoT, data analytics, and healthcare, investing primarily during Seed and Series A rounds. ACT aims to back technically strong founders who are pioneering disruptive, market-transforming solutions. Some notable companies in their portfolio include Picus Security, Carbon Health, Eatron, and Nextmol. The firm typically leads seed rounds with checks up to €1 million, often continuing to support portfolio companies in subsequent funding rounds. Their investment strategy emphasizes hands-on collaboration, providing not only financial backing but also mentorship, networking, and strategic advice to help startups achieve critical product-market fit and scale. The core team comprises experienced professionals with backgrounds in engineering, finance, and entrepreneurship. Key figures include managing partners Erhan Kılıçözlü and Okan Kara, who bring decades of experience in tech transfer, venture capital, and innovation management, contributing to ACT's reputation as a value-adding partner for startups. ACT's approach involves close engagement from initial funding through to growth stages, leveraging their extensive network across Europe and beyond.

Action Potential Venture Capital (APVC) is a leading medical technology venture capital firm founded by GlaxoSmithKline (GSK) in 2013. The firm focuses on advancing bioelectronic medicines and enabling technologies. APVC is headquartered in Cambridge, Massachusetts, with additional offices in Scotts Valley, California. APVC invests in companies that leverage advances in hardware, computing, and material science to regulate neural or cellular activity, aiming to treat a range of chronic diseases. Notable portfolio companies include Cala Health, which develops non-invasive neuromodulation therapies for conditions like essential tremor; CVRx, known for its FDA-approved BAROSTIM NEO therapy for heart failure; and Neuspera Medical, which is developing minimally invasive neuromodulation therapies for overactive bladder. The firm takes a hands-on role on the boards of startups, providing strategic guidance and support. APVC has made 25 investments to date, with recent notable investments in Exo, which offers AI-enabled handheld ultrasound imaging, and MicroTransponder, which focuses on therapies for neurological conditions. APVC's investment approach emphasizes diversity and inclusion within the healthcare and entrepreneurial communities. The leadership team includes Imran Eba and Juan-Pablo Mas, who bring extensive experience in venture capital and biotechnology investments.

Activant Capital, founded in 2015, is a venture capital firm that focuses on investing in companies during critical growth phases. With headquarters in Greenwich, Connecticut, and additional offices in New York, Berlin, and Cape Town, the firm has over $1 billion in assets under management. Activant Capital invests in various sectors, including fintech, supply chain, e-commerce, retail technology, and health tech. The firm has a strong portfolio featuring companies such as Boom Supersonic, DEUNA, Deliverr, Current, Finix, and Forter. Boom Supersonic is developing a new generation of supersonic commercial airliners, while Deliverr provides rapid e-commerce fulfillment solutions. Forter specializes in fraud prevention for online retailers, and Finix offers payment infrastructure for businesses. Activant Capital is known for its thesis-driven approach, concentrating on commerce infrastructure technology that enhances efficiency across industries. Their investment strategy emphasizes partnering with high-growth companies to redefine commerce systems. They provide extensive operational support to their portfolio companies, assisting with organizational structure, hiring, go-to-market strategies, and commercial introductions. The firm has also achieved several notable exits, including Hybris, which was sold to SAP for $1.4 billion, and Deliverr, highlighting their ability to identify and support transformative companies. Activant’s approach is to remain long-term partners, with fund lives extending up to 15 years to support the ambitious growth of their portfolio companies.

Activate Venture Partners, formerly known as Milestone Venture Partners, is an early-stage venture capital firm founded in 1999 and based in New York City. The firm focuses on investing in high-growth technology companies, particularly those in the healthcare and enterprise software sectors. Their strategy emphasizes being the first institutional investor in startups, with over 85% of their portfolio companies receiving pre-revenue investments​. Notable investments in their portfolio include companies like Healthify, Diameter Health, and Cureatr, reflecting their strong focus on healthcare technology. Additionally, they have invested in technology firms like Canvs.ai and Cloudnexa, which provide services ranging from market research to AWS management. Activate Venture Partners typically leads seed and early-stage financing rounds with initial investments often below $5 million. They are known for their hands-on approach, offering strategic guidance and support to help startups scale effectively. The leadership team includes co-founders Edwin Goodman and Todd Pietri, along with partners like Glen Bressner and Don Yount. Their extensive experience and deep industry connections provide valuable insights and resources to the companies they invest in​.

Active Capital is a venture capital firm based in San Antonio, Texas, that focuses on leading seed-stage investments, primarily in B2B SaaS companies. Founded by Pat Matthews, Active Capital aims to support startups that are building cloud-based software and infrastructure with the potential to scale rapidly. The firm typically writes checks ranging from $500,000 to $2 million and prides itself on being highly involved with its portfolio companies, offering hands-on support to help them grow from seed to later stages. Active Capital is particularly active in markets outside of Silicon Valley, seeking to back talented entrepreneurs across the U.S. who are often overlooked by more geographically concentrated funds. Their portfolio includes notable companies like CallRail, LawnStarter, and Bestow, all of which are examples of scalable B2B solutions that align with their investment thesis​. The firm is committed to leading rounds, often taking a lead role in both investments and operational guidance. Active Capital prefers to work closely with founders who are building high-growth SaaS platforms, leveraging its extensive network of industry experts and fellow investors. With a focus on long-term partnerships, Active Capital is positioned as a strategic ally for early-stage companies that are ready to accelerate their market entry and growth.

Acumen is a pioneering impact investment firm dedicated to addressing poverty through a unique approach it calls “patient capital,” designed to fund social enterprises that serve the most marginalized populations. Since its inception in 2001 by Jacqueline Novogratz, Acumen has invested over $150 million across 150+ companies worldwide. Its portfolio spans essential sectors like clean energy, agriculture, healthcare, and education, all aimed at empowering low-income communities with sustainable solutions that can operate at scale. Acumen’s methodology combines financial investment with a strong emphasis on management and leadership support. By focusing on long-term growth rather than immediate returns, Acumen supports businesses in emerging markets like East and West Africa, India, Latin America, and the U.S., ensuring they grow in both impact and profitability. Some of their prominent initiatives, such as off-grid energy projects in sub-Saharan Africa and affordable healthcare solutions in South Asia, reflect their commitment to transforming critical services for underserved populations. In addition to financial investment, Acumen fosters a culture of moral leadership through Acumen Academy, which educates entrepreneurs and social innovators on creating impactful and inclusive businesses. This dual approach of investment and training allows Acumen to build a pipeline of leaders and companies equipped to drive systemic change. With an extensive global network and partners ranging from corporate foundations to local entrepreneurs, Acumen continually expands its reach, working tirelessly to reimagine the role of capital in tackling poverty.

Acumen America is a venture capital arm of Acumen, founded in 2016 with a mission to tackle systemic poverty and inequality in the U.S. by investing in entrepreneurs with bold, scalable solutions. Their focus spans three main sectors: health, workforce development, and financial inclusion. They back early-stage, mission-driven companies addressing challenges like healthcare access, financial instability, and career mobility, often being the first to write a check at the pre-seed or seed stage. Acumen America’s portfolio includes companies such as Esusu, which helps renters build credit, Flourish, providing mental health services for young adults, and Everytable, which makes nutritious food accessible to low-income communities. They prioritize overlooked founders, with 60% of their portfolio led by people of color and 44% by women. Their investment strategy centers on systems change, aiming to bring enduring impact to underserved communities by supporting entrepreneurs who can disrupt industries like healthcare and financial services. They work closely with their portfolio companies, providing not just capital but deep operational support to scale impactful solutions.

Ada Ventures is a London-based venture capital firm focused on supporting early-stage startups with a particular emphasis on diversity and inclusion. Founded by Check Warner and Matt Penneycard, Ada Ventures aims to back founders who are often overlooked and underfunded, targeting sectors like climate equity, economic empowerment, and healthy aging​. The firm typically makes initial investments of around £500,000 and has developed innovative deal-sourcing methods, including a scout network and angel investment programs to reach underrepresented communities. This approach has led to successful investments in companies such as Huboo, Organize, and MOONHUB. Ada Ventures' portfolio from its first fund has raised an aggregate of £100 million in additional funding from prominent firms like GV and Index Ventures. Ada Ventures recently launched its second fund, raising £41 million in the first close, demonstrating strong support from the investor community and its commitment to creating a more inclusive venture capital landscape.

Adams Street Partners, founded in 1972, is a global leader in private markets investment management, with over $60 billion in assets under management. Based in Chicago, the firm operates across North America, Europe, and Asia-Pacific, investing through strategies that include primary, secondary, growth equity, credit, and co-investments. Adams Street Partners is particularly known for its expertise in venture capital, private equity, and fund of funds strategies. The firm has a long history of venture capital investments, having been active in the space since the 1970s. Their venture capital portfolio focuses on innovative, high-growth sectors such as healthcare, AI, enterprise software, and fintech. Adams Street also manages dedicated funds for early-stage companies and emerging managers. The firm’s strategic investment approach is designed to generate strong, risk-adjusted returns over time by supporting companies through market cycles and downturns. Adams Street Partners continues to build on its reputation by backing both new startups and established companies, making significant contributions to technological and industrial advancements. With a focus on long-term growth and innovation, the firm remains a prominent player in global private equity and venture capital.

Adapt Ventures is an early-stage venture capital firm with a global focus, investing in founders who have bold visions in sectors like fintech, software, healthcare, and consumer products. The firm typically writes checks ranging from $100,000 to $500,000 at the pre-seed and seed stages, intentionally not leading rounds or taking board seats to give founders autonomy. Their portfolio includes companies like Sanas, Clara, and Wander, showcasing their commitment to transformative, high-impact startups. Founded by brothers Ammar and Mohammed Amdani, Adapt takes a collaborative approach, ensuring hands-on support for their portfolio companies through each growth phase. The firm is well-known for leveraging its extensive network to assist startups with business development, fundraising, and scaling into new markets. This founder-first philosophy, coupled with a high degree of engagement, sets them apart in the VC space. Adapt Ventures has offices in Miami, New York, and Dubai, reflecting their broad geographic reach. The team, which includes partners like Ezra Kebrab and Alan Chang, brings deep expertise in areas like fintech, proptech, and consumer brands, providing founders with the resources and insights needed to scale their companies rapidly. With a goal of investing in around 10 to 12 new companies each year, Adapt offers focused, high-value support to its portfolio, making them a go-to partner for early-stage entrepreneurs.

Adara Ventures, founded in 2005 and headquartered in Madrid, Spain, specializes in early-stage investments in deep tech companies, focusing on sectors like cybersecurity, data and applications, infrastructure, DevOps, components, and digital health. Managing around €200 million in assets, Adara has invested in 85 companies. Their portfolio includes notable companies such as Seedtag, Scalefast, and AlienVault. Seedtag, a leader in Contextual AI for the AdTech industry, is one of their standout investments. Adara led Seedtag's initial €1.5 million round and has supported the company through its significant growth and recent €250 million funding round led by Advent International. Adara has seen several successful exits, including AT&T Cybersecurity and PlayGiga, showcasing their ability to identify and nurture high-potential startups. They typically invest in seed, Series A, and Series B rounds, with check sizes ranging from $500,000 to $3 million. The Adara team includes experienced professionals like Managing Partners Alberto Gómez and Nicolas Goulet, and Partner Alberto Echeverri, who bring extensive expertise to support their portfolio companies' growth and success. Adara Ventures continues to play a significant role in the European venture capital landscape, particularly in Spain and Western Europe.

AdBio Partners, previously known as Advent France Biotechnology, is a Paris-based venture capital firm specializing in early-stage investments within the life sciences sector. Established in 2016, AdBio Partners focuses on identifying and nurturing promising startups across Europe, particularly in France, Belgium, Spain, and Ireland. Their investment strategy is centered on therapeutics, supporting innovative biotech projects with high potential to address unmet medical needs. The firm is deeply integrated into the European life sciences ecosystem, collaborating closely with research institutions and technology transfer offices to transform groundbreaking scientific discoveries into viable businesses. AdBio Partners also plays an active role in the development of its portfolio companies, often co-founding and providing hands-on operational support to ensure their growth and success. Led by an experienced team of professionals with extensive backgrounds in science, medicine, and entrepreneurship, AdBio Partners has successfully attracted international VC syndicates, further strengthening its portfolio. Some notable companies backed by AdBio include DiogenX and ARTHEx Biotech.

Addition is a venture capital firm founded in 2019 by Lee Fixel, previously a key investor at Tiger Global. Based in New York, Addition focuses on early and growth-stage technology companies, emphasizing sectors like e-commerce, SaaS, and fintech. Their notable investments include high-profile companies such as Allbirds, Freshworks, Chainalysis, Delhivery, dLocal, Hugging Face, Snyk, and Warby Parker. Geographically, Addition primarily targets investments in the United States, though they have a broad international scope due to their interest in global tech innovators. Their investment strategy involves a significant allocation towards both early-stage and growth-stage companies, with about one-third of their capital dedicated to early-stage ventures and the rest to more mature businesses. This allows them to support startups through various phases of their development. Addition's team is led by Fixel, who is the sole partner and decision-maker, ensuring a streamlined and decisive investment process. The firm is known for its strategic and empathetic approach, focusing on building long-term partnerships with entrepreneurs and fostering growth in their portfolio companies through active engagement and support. For startups seeking investment, Addition values clear demonstrations of potential for market leadership and significant growth. They prefer companies with a proven track record of profitability and sustainable competitive advantages. The firm's commitment to preserving legacy and company culture makes them a preferred partner for founders looking for a strategic, long-term investor.

Adjacent is an early-stage venture capital firm led by Nico Wittenborn, a seasoned investor with prior experience at Point Nine Capital and Insight Partners. The fund stands out for its investments in high-growth, tech-driven companies such as Revolut, Chainalysis, Oura, and PhotoRoom. With a clear focus on the intersection of consumer technology and SaaS, Adjacent targets startups building platform-shifting innovations. Geographically, Adjacent leans towards U.S. and European markets, especially major hubs like New York and Paris. Their strategy is centered on relatively small, early-stage investments, often writing checks around $2-5M. Though the fund typically doesn't lead rounds, it plays a crucial role as a follow-on investor, backing companies that demonstrate early signs of scaling potential. Wittenborn's philosophy is rooted in not chasing $10B outcomes but rather in building a highly concentrated, collaborative portfolio. The fund invests across sectors like fintech, AI, and mobile applications, with recent deals including RevenueCat, Copilot, and Ostrom. Founders seeking to engage Adjacent are best suited to focus on scalability and clear market traction, as Wittenborn prefers lean operations with strong growth signals. The team operates from New York and actively reduces the number of companies they engage with to maintain close founder relationships.

ATV Capital (Advanced Technology Ventures) is an established venture capital firm specializing in early-stage investments across IT, healthcare, and energy technology sectors. With offices in Boston and Menlo Park, ATV focuses on backing high-potential companies driving innovation in these industries. The firm typically leads rounds, partnering closely with founders to provide strategic guidance and leverage its extensive network in Silicon Valley and beyond. ATV's portfolio includes a mix of disruptive startups in sectors like enterprise software, biotech, medical devices, and clean energy. It aims to identify companies that can scale rapidly while solving critical technological or medical challenges. Although primarily US-focused, ATV occasionally considers international opportunities if they align with its strategic vision and offer strong potential for growth. The firm’s investment strategy revolves around early-stage funding, typically from Series A onward, with average check sizes ranging from $5 to $15 million. ATV is known for its active involvement, often serving on boards and offering ongoing operational and strategic support. ATV’s leadership team includes seasoned investors and industry veterans who bring decades of experience in venture capital, technology, and healthcare. Founders are encouraged to approach ATV with a strong business case, significant market traction, and a clear path to scalability. With a focus on building long-term partnerships, ATV positions itself as more than just a financial backer, but as a critical player in helping startups navigate their growth journey.

Advancit Capital is a venture capital firm founded in 2011, focusing on early-stage investments in media, technology, and web3 startups. Co-founded by Shari Redstone and Jason Ostheimer, the firm leverages its deep industry relationships and strategic support to help accelerate the growth of its portfolio companies. Advancit Capital's notable investments include The Athletic, an online sports media company; Headspace, a provider of guided meditation and mindfulness training; and Thrive Global, a platform for mental well-being coaching. They also have investments in Public, a multi-asset investment platform, and Mux, a video performance monitoring platform. The firm has a portfolio of over 100 companies and has seen several successful exits, including the acquisitions of Wondery, a podcast streaming platform, and Mic, a media company targeting millennials. With a strong emphasis on forming long-term partnerships, Advancit Capital continues to support innovative startups addressing large opportunities ripe for disruption.

ADvantage VC is a venture capital firm focused on sports technology, investing in early-stage companies that are transforming the sports and entertainment industries. Founded in 2018 by Alexander Bente, great-grandson of adidas founder Adi Dassler, ADvantage builds on a legacy of sports innovation. The firm backs startups developing cutting-edge solutions in areas such as sports performance, media, fan engagement, and wearables. ADvantage has an impressive portfolio, including companies like Playermaker, a wearable tracking platform for athletes, Track160, which provides AI-driven performance analytics for soccer, and TAPPP, a service enabling interactive sports betting and content access. The firm also invests in platforms like Rooter, India's leading game streaming platform, and Flexia, which is reinventing Pilates with connected hardware. With partners based in Israel, including venture capitalist Jeremy Pressman, ADvantage is a global player. Their focus is on backing visionary entrepreneurs who are reshaping how fans and athletes experience sports.

Advantage Capital is a prominent impact investment firm founded in 1992, dedicated to providing financing to businesses and communities often overlooked by traditional capital sources. The firm has invested over $4.2 billion in more than 800 companies across various industries, including technology, renewable energy, and affordable housing. Some of their notable investments include NevadaNanotech Systems, which develops portable devices for real-time chemical analysis, and North End Teleservices, a contact center services provider in North Omaha aimed at creating local jobs and economic growth. TurboSquid, a global online marketplace for digital 3D models, is another key investment that highlights Advantage Capital's support for tech innovation and economic development in New Orleans​​. Advantage Capital emphasizes impact investing, focusing on outcomes such as job creation, community revitalization, and environmental sustainability. In 2022, the firm invested $85 million in affordable housing and raised over $635 million for solar energy projects, underscoring their commitment to driving meaningful change in underserved areas.

Advent Life Sciences is a leading transatlantic venture capital firm that focuses on investing in early and mid-stage life sciences companies. The firm emphasizes innovation in areas such as new drug discovery, medical technology, enabling technologies, and vaccines. Advent Life Sciences takes a hands-on approach, working closely with management teams to bring their visions to life, aiming for superior financial returns by bringing innovative solutions to patients. Advent Life Sciences has a strong portfolio of companies that have brought significant advancements in healthcare. Notable investments include AviadoBio, which focuses on gene therapy for neurodegenerative disorders, and Amphista Therapeutics, which develops protein degradation technologies for targeted cancer therapies. The firm also backs companies like Cellnovo, which created a micro insulin pump with connectivity, and Centessa Pharmaceuticals, a novel asset-centric pharmaceutical company. The firm is known for its experienced team of professionals, combining deep technical, commercial, and financial expertise. Key team members include Don Drakeman, Majid Kazmi, and Katrine Bosley, who bring substantial industry knowledge and strategic guidance to their portfolio companies. Advent Life Sciences is committed to supporting the growth of life sciences innovations, helping companies navigate the complex journey from scientific discovery to market-ready products.

adVentures Studio is a Paris-based startup studio that focuses on building ventures targeting niche global markets. With a strong presence in Paris, New York, and San Francisco, they specialize in creating companies that address complex challenges through cutting-edge technologies, particularly in sectors like genetic engineering, AI, deep tech, and cleantech. Each startup in their portfolio is crafted with the goal of delivering not just financial success but also contributing to the common good, often with a focus on sustainable development and social impact. Their unique model blends young talents with experienced entrepreneurs and scientists, fostering innovation through a dynamic mix of expertise. adVentures uses an agile, experimental approach to developing ventures, allowing them to pivot quickly and scale efficiently. Some of their notable ventures include Wimi, a teamwork solution platform, and GEG-Tech, a pioneer in gene transfer technologies for life sciences. They also emphasize impact-driven businesses, such as BXVentures, which is dedicated to building cleantech startups for a net-zero carbon society. Led by founder Antoine Duboscq, adVentures operates with a clear mission: to breed leaders in niche markets through visionary entrepreneurship and technological innovation. They actively support ventures with agile strategies, ensuring sustainable growth and value creation across their portfolio.

Aera VC is a venture capital firm focused on investing in climate tech and frontier technologies that aim to advance humanity and create a sustainable future. Founded in 2016 by Derek Handley and Nick Winstone, Aera VC operates from New York, Singapore, and New Zealand. The firm invests globally, targeting early-stage companies that drive transformational change across various industries. Notable investments include Solugen, which transforms chemicals using plant-based processes, and Twelve, a company that recycles CO₂ into cost-competitive chemicals and fuels. Other significant investments are Shiok Meats, a Singapore-based company developing cell-based seafood, and Carbon Chain, which offers solutions to reduce greenhouse gas emissions in supply chains. Aera VC also supports startups like AstroForge, focused on space technology, and Paloma Health, an online medical practice specializing in hypothyroidism. Aera VC recently raised $42 million in the first close of its new climate-focused fund, which will be used to back up to 30 new seed investments over the next two years. The firm aims to support breakthrough technologies that can significantly reduce the world's carbon footprint and advance sustainable practices across various sectors.

Aescuvest is a prominent pan-European venture capital firm that specializes in health technology. Headquartered in Frankfurt, Germany, Aescuvest collaborates with EIT Health, giving it exclusive access to some of the most promising healthtech startups across Europe. The firm focuses on early to late-stage ventures, investing in areas such as remote monitoring, diagnostics, personalized medicine, and AI in healthcare. Notable investments include startups like Neteera and Caresyntax, showcasing their commitment to advancing healthcare technology. Aescuvest's strategy emphasizes a rigorous selection process and thorough due diligence to ensure exponential growth potential for their investments. They prefer to lead funding rounds and remain actively involved in the growth of their portfolio companies. Aescuvest targets investments primarily within Europe and Israel, fostering a network of healthcare technology-driven investors, including business angels and corporate investors. The fund's typical investment size averages around $2.85 million per round. For startups seeking investment, Aescuvest values innovation that promises substantial improvements in patient outcomes and healthcare delivery. Their approach to building an investment funnel involves leveraging partnerships and a deep understanding of the healthtech sector to identify high-impact opportunities. Key team members include experts deeply rooted in the healthcare industry, such as Helmut Nanz, whose experience and strategic insight drive Aescuvest's mission to transform healthcare through technology.

AF Ventures, formerly known as AccelFoods, is a venture capital firm based in New York that invests in high-growth consumer product companies. Established in 2014, the firm focuses on sectors such as food and beverage, health and wellness, personal and household care, beauty, and pet products. AF Ventures typically invests in companies with $10-30M+ in top-line revenue, aiming to support the creation of enduring brands. Notable investments by AF Ventures include Harmless Harvest, ByHeart, Proud Source Water, Koia, Siete Foods, and Hello Bello. The firm provides financial capital along with strategic support, leveraging a network of industry experts to help portfolio companies achieve significant growth and innovation. AF Ventures is committed to driving consumer brand innovation on retail shelves and online platforms. They manage over 35 portfolio brands and continue to identify and support companies that offer unique and disruptive products in their respective markets.

Afore Capital is a San Francisco-based venture capital firm specializing in pre-seed stage investments. Founded in 2016, Afore Capital manages a $300 million fund and typically invests $500,000 to $2 million in early-stage companies that are pre-traction and pre-revenue. The firm focuses on identifying high-potential startups and helping them rapidly scale towards Series A funding rounds. Afore Capital’s diverse portfolio includes companies across sectors such as SaaS, fintech, healthcare, consumer, and enterprise technology. Notable investments include Neo Financial, a digital bank; BetterUp, a platform for professional coaching; and Curefit, a provider of digital and offline fitness services. The firm has a strong track record, with several successful exits and notable co-investments alongside top venture funds like Andreessen Horowitz and Accel​.

AgFunder is a venture capital firm founded in 2013, with headquarters in Silicon Valley. The firm focuses on investing in transformative technologies within the food and agriculture sectors. Their investment strategy emphasizes bold and impactful innovations that address critical challenges such as climate change, population growth, and sustainability in food production. Notable investments in AgFunder's portfolio include companies like DeHaat, which is a farmers' business network for smallholder farmers, and MycoWorks, known for producing leather alternatives from mycelium. Other significant investments include Verdant Robotics, a robotics-as-a-service company specializing in agricultural spraying, and Wefarm, a peer-to-peer network for farmers in Eastern Africa. AgFunder's thematic investment approach targets high-impact areas such as indoor farming, precision agriculture, and alternative proteins. They leverage their extensive network of founders, operators, and investors to support their portfolio companies in scaling globally. The firm has raised multiple funds and invested in over 85 companies, making them one of the most active foodtech and agtech VCs worldwide. Their leadership team combines technological expertise with market knowledge, enabling them to support startups effectively from early stages through to larger growth phases. AgFunder’s mission is to drive radical transformation in the food and agriculture systems through advanced technologies​.

Aglaé Ventures is a global technology-focused investment firm established in 2017, with headquarters in Paris and offices in New York and San Francisco. The firm is backed by Agache (formerly Groupe Arnault), the principal investment vehicle of Bernard Arnault, the controlling shareholder of LVMH. Aglaé Ventures invests in fast-growing tech companies at all stages, from seed to pre-IPO rounds, with investment sizes ranging from €100K to €100MM. Notable investments by Aglaé Ventures include high-profile companies such as Airbnb, Slack, Spotify, and Lyft. The firm is sector-agnostic but concentrates on asset-light and scalable business models, particularly in marketplaces, SaaS, content platforms, consumer apps, and digitally native vertical brands. Aglaé Ventures emphasizes a long-term investment approach, providing flexible and enduring capital while supporting portfolio companies with expertise in growth management, brand building, digital marketing, and global expansion strategies. The firm also leverages its extensive network, including access to the LVMH ecosystem, to accelerate the growth of its portfolio companies. The team at Aglaé Ventures includes experienced investors and entrepreneurs like Miyuki Matsumoto, Managing Partner and Head of US Investments, and co-founders Cyril Guenoun and Antoine Loison. The firm prides itself on its simple investment terms and quick decision-making processes, making it an attractive partner for ambitious founders​.

Agronomics is a London-listed investment firm leading the charge in cellular agriculture, a field focused on producing agricultural products directly from cell cultures rather than through traditional farming. This approach holds promise in addressing critical issues like climate change, deforestation, and food insecurity. Agronomics invests in ventures aiming to disrupt animal husbandry and conventional food production, focusing on meat, dairy, leather, and other products derived through cutting-edge biotechnology, precision fermentation, and tissue engineering. Their portfolio includes over 20 companies, such as Meatable, a cultivated meat firm specializing in pork and beef, and BlueNalu, which is developing cell-based seafood products. These startups are pioneering solutions to replace conventional protein sources with more sustainable alternatives, reducing environmental impact and improving food security. Agronomics typically targets early-stage investments, leveraging its expertise to support companies through technological and regulatory challenges. The firm invests globally, with a particular focus on the rapidly growing precision fermentation and cellular agriculture sectors. Their goal is to not only provide capital but also help drive regulatory approvals and scalability for sustainable food production. Led by co-founders Jim Mellon and Denham Eke, Agronomics offers a unique blend of financial and scientific insight. Their active approach includes deep involvement in company growth strategies, particularly around impact and sustainability metrics. This positions Agronomics as a leader in shaping the future of food technology.